Anne‐Marie Baird

2.7k citations

61 papers · 1.6k indexed · 1 hit paper · h-index 21

Molecular Biology top 10%
Cancer Research top 2%
Oncology top 10%
Pulmonary and Respiratory Medicine top 10%
Immunology

Co-authors: Stephen P. Finn Steven G. Gray Ray McDermott Kenneth J. O’Byrne Marvin Lim John Greene Lauren Brady Kathy Gately
Topics: Cancer Genomics and Diagnostics (10 papers)Prostate Cancer Treatment and Research (10 papers)Cancer-related molecular mechanisms research (6 papers)
Cited by: Cancer Research Molecular Biology Oncology
Journals: Journal of Clinical Oncology The Journal of Immunology PLoS ONE
Partner nations: Ireland Australia United Kingdom

In The Last Decade

Anne‐Marie Baird

57 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNAs: Biogenesis, Function and Role in Human Diseases

2017 442 citations John Greene, Anne‐Marie Baird et al. profile →

Peers

Countries citing papers authored by Anne‐Marie Baird

Since Specialization

Citations

This map shows the geographic impact of Anne‐Marie Baird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Marie Baird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Marie Baird more than expected).

Fields of papers citing papers by Anne‐Marie Baird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Marie Baird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Marie Baird. The network helps show where Anne‐Marie Baird may publish in the future.

Co-authorship network of co-authors of Anne‐Marie Baird

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Marie Baird. A scholar is included among the top collaborators of Anne‐Marie Baird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Marie Baird. Anne‐Marie Baird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing the impact of digital patient monitoring on health outcomes and healthcare resource usage in addition to the feasibility of its combination with at-home treatment, in participants receiving systemic anticancer treatment in clinical practice: protocol for an interventional, open-label, multicountry platform study (ORIGAMA) 2023 ·BMJ Open ·Sanna Iivanainen,Anne‐Marie Baird,Bogdana Balas,(unknown),(unknown),Manuela Eicher,Sophie Golding,(unknown),María Reig,Manfred Welslau,(unknown)	5
2	How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action 2023 ·Health Science Reports ·Anne‐Marie Baird,C. Benedikt Westphalen,(unknown),Begonya Nafría,(unknown),Ify Sargeant,(unknown),(unknown),(unknown),Durhane Wong‐Rieger	10
3	The need for a comprehensive and integrated approach to lung cancer policy in Europe 2022 ·European Journal of Cancer ·(unknown),Eleanor Wheeler,Suzanne Wait,Tit Albreht,Anne‐Marie Baird,Jacek Jassem,(unknown),Silvia Novello,Cornel Radu-Loghin,Jan P. van Meerbeeck	3
4	How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma? 2022 ·Healthcare ·Denis Horgan,Anne‐Marie Baird,Mark R. Middleton,(unknown),Jan P. van Meerbeeck,Jens Vogel‐Claussen,Paul Van Schil,Josep Malvehy,Paolo A. Ascierto,(unknown),(unknown),Jonathan A. Lal,Grażyna Kamińska‐Winciorek,Marco Donia,Thierry André,(unknown),Pia Österlund,Dan L. Dumitraşcu,Luca Bertolaccini	4
5	Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids 2021 ·Journal of Nanobiotechnology ·(unknown),Mustafa Kotmakçı,Anne‐Marie Baird,Steven G. Gray,Bilge Debeleç-Bütüner,Emir Bozkurt,Ayşe Gülten Kantarcı,Stephen P. Finn	44
6	Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer 2021 ·Clinical Epigenetics ·(unknown),Bruce Moran,Anne‐Marie Baird,Colm J. O’Rourke,Stephen P. Finn,Ray McDermott,William Watson,William M. Gallagher,Donal J. Brennan,Antoinette S. Perry	19
7	Vaping and lung cancer – A review of current data and recommendations 2021 ·Lung Cancer ·Dara Bracken‐Clarke,(unknown),Anne‐Marie Baird,Paul Buchanan,Kathy Gately,Sinéad Cuffe,Stephen P. Finn	79
8	Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer 2021 ·Frontiers in Oncology ·(unknown),Keyur A. Dave,(unknown),(unknown),(unknown),(unknown),Christopher J. Molloy,Neha S. Gandhi,Eric D. Boittier,Connor O’Leary,Esha T. Shah,Emma Bolderson,Anne‐Marie Baird,Derek J. Richard,Kenneth J. O’Byrne,Mark N. Adams	6
9	Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer 2021 ·Frontiers in Cell and Developmental Biology ·John Greene,Anne‐Marie Baird,Marvin Lim,(unknown),(unknown),Lauren Brady,Orla Sheils,Steven G. Gray,Ray McDermott,Stephen P. Finn	15
10	Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer 2021 ·Cancer Treatment and Research Communications ·Lauren Brady,Jessica Carlsson,Anne‐Marie Baird,Órla Casey,Tatjana Vlajnic,(unknown),(unknown),Danielle C. Costigan,Steven G. Gray,Orla Sheils,Amanda O’Neill,R. William G. Watson,Ove Andrén,Stephen P. Finn	8
11	Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness 2020 ·Scientific Reports ·Louise Flynn,Martin P. Barr,Anne‐Marie Baird,Paul Smyth,Órla Casey,Gordon Blackshields,John Greene,Stephen R. Pennington,Emily Hams,Padraic G. Fallon,John O’Leary,Orla Sheils,Stephen P. Finn	10
12	European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer 2020 ·Lung Cancer ·Thierry Berghmans,Yolande Lievens,Matti Aapro,Anne‐Marie Baird,Marc Beishon,Fiorella Calabrese,Csaba László Dégi,Roberto C. Delgado Bolton,Mina Gaga,József Lövey,Andrea Luciani,(unknown),Helmut Prosch,M. Saar,Michael Shackcloth,(unknown),Alberto Costa,Philip Poortmans	31
13	Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC 2019 ·Lung Cancer ·(unknown),(unknown),Martin P. Barr,(unknown),Susan Heavey,P. Godwin,Steven G. Gray,(unknown),Stephen P. Finn,Kathy Gately,Anthony M. Davies,Erik W. Thompson,Derek J. Richard,Kenneth J. O’Byrne,Mark N. Adams,Anne‐Marie Baird	26
14	P3.01-064 The Overexpression and Cleavage of SASH1 by Caspase-3 Stimulates Cell Death in Lung Cancer Cells 2017 ·Journal of Thoracic Oncology ·Joshua T. Burgess,Emma Bolderson,Steven G. Gray,Martin P. Barr,Kathy Gately,Shudong Zhang,Anne‐Marie Baird,Derek J. Richard,Kenneth J. O’Byrne	1
15	Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture 2016 ·Assay and Drug Development Technologies ·(unknown),Anne‐Marie Baird,(unknown),Aaron Urquhart,Mathias O. Senge,Derek J. Richard,Kenneth J. O’Byrne,Anthony M. Davies	81
16	Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response 2016 ·QUT ePrints (Queensland University of Technology) ·Joshua T. Burgess,Emma Bolderson,Mark N. Adams,Anne‐Marie Baird,Shudong Zhang,Kathy Gately,Kazuo Umezawa,Kenneth J. O’Byrne,Derek J. Richard	2
17	Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response 2016 ·Cell Death and Disease ·Joshua T. Burgess,Emma Bolderson,Mark N. Adams,Anne‐Marie Baird,Shudong Zhang,Kathy Gately,Kazuo Umezawa,Kenneth J. O’Byrne,Derek J. Richard	22
18	IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer 2013 ·Frontiers in Oncology ·Anne‐Marie Baird,(unknown),Ann K. Daly,(unknown),Derek G. Doherty,Kenneth J. O’Byrne,Steven G. Gray	16
19	Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy 2013 ·Frontiers in Oncology ·P. Godwin,Anne‐Marie Baird,Susan Heavey,Martin P. Barr,Kenneth J. O’Byrne,Kathy Gately	238
20	Plant mitochondrial nucleoside diphosphate kinase is attached to the membrane through interaction with the adenine nucleotide translocator 2003 ·FEBS Letters ·Carina Knorpp,Monika Johansson,Anne‐Marie Baird	23

About Anne‐Marie Baird

Anne‐Marie Baird is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Prostate Cancer Treatment and Research (10 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (764 citations), Molecular Biology (1.0k citations) and Oncology (316 citations). Anne‐Marie Baird has collaborated with scholars based in Ireland, Australia and United Kingdom. Frequent co-authors include Stephen P. Finn, Steven G. Gray, Ray McDermott, Kenneth J. O’Byrne, Marvin Lim, John Greene, Lauren Brady, Kathy Gately, Martin P. Barr and P. Godwin. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact